Substance Dependence Clinical Trial
Official title:
Distress Tolerance Treatment for Substance Users
Despite recent advances in substance abuse interventions, a large percentage of clients
entering residential treatment for substance use will drop out of treatment prematurely, and
of the remaining, many will relapse soon after treatment completion. Previous research
indicates that an individual's ability to withstand psychological distress is a key factor
necessary to maintain drug and alcohol abstinence and to remain in substance use treatment
without absconding. In previous work, Dr. Bornovalova developed a specific distress tolerance
treatment called Skills for Improving Distress Intolerance (SIDI). This intervention features
skills training in behavioral and acceptance strategies and intentional clinical exposure to
emotional distress. SIDI was developed and piloted with a sample of urban drug users seeking
treatment in a residential facility. Individuals receiving SIDI exhibited greater improvement
in distress tolerance than those in two comparison groups (receiving treatment-as-usual and
supportive counseling).
Current study. The investigators received NIDA funding to conduct a randomized clinical trial
with 325 clients entering a residential substance use treatment facility. Study participants
will be randomized into two treatment groups: (1) those receiving SIDI and (2) those
receiving Supportive Counseling (SC). Participants will receive 10 treatment sessions over a
period of 4 months. Then, the investigators will follow clients for one year to examine
treatment retention and abstinence.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00887367 -
EtOH Interaction Study
|
Phase 1 | |
| Completed |
NCT01036061 -
GSK618334 Repeat Dose Study
|
Phase 1 | |
| Completed |
NCT01189799 -
Motivational Therapy for Substance Users With Depression
|
N/A | |
| Completed |
NCT01381133 -
Adolescent Outpatient and Continuing Care Study
|
Phase 3 | |
| Recruiting |
NCT04430257 -
Pre-exposure Prophylaxis (PrEP) for Health
|
N/A | |
| Completed |
NCT01128140 -
Efficacy Trial of Warrior Check-Up
|
Phase 2 | |
| Completed |
NCT03767907 -
Online Cognitive Behavioural Therapy for Addiction: Efficacy and Cost-Effectiveness in a Pragmatic Clinical Trial
|
N/A | |
| Recruiting |
NCT05833399 -
Correlation of Genetic Variations With Clinical Response in Substance Use Disorder
|
||
| Withdrawn |
NCT01515917 -
Citicoline and Omega-3 Fatty Acid Effects in Veterans With Traumatic Brain Injury (TBI)
|
N/A | |
| Completed |
NCT00208143 -
Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia
|
Phase 4 | |
| Withdrawn |
NCT03762798 -
Can The Bridge Transition Opiate Use Disorder Patients in Stable Recovery From Buprenorphine to Naltrexone
|
N/A | |
| Completed |
NCT03048552 -
Family Engagement, Cross-System Linkage to Substance Use Treatment for Juvenile Probationers -- Phase 3
|
N/A | |
| Active, not recruiting |
NCT04768920 -
Examining Feasibility and Acceptability of Telemedicine for Substance Use Disorder (SUD)
|
N/A | |
| Recruiting |
NCT05410561 -
Harnessing Telemedicine to Improve Alcohol Use Disorder Outcomes in Primary Care Patients
|
N/A | |
| Recruiting |
NCT05679284 -
A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs
|
||
| Withdrawn |
NCT00908206 -
Effects of GSK598809 on Brain Activation in Abstinent Alcoholics
|
Phase 1 | |
| Recruiting |
NCT05348317 -
Developing a Telehealth Model to Improve Treatment Access for Rural Veterans With Substance Use Disorders
|
N/A | |
| Active, not recruiting |
NCT01621711 -
Continuing Care Following Drug Abuse Treatment: Linkage With Primary Care
|
N/A | |
| Active, not recruiting |
NCT00609089 -
Community Reinforcement and Family Training for Drug Abuse Treatment Retention/HIV Risk Reduction
|
Phase 1/Phase 2 | |
| Completed |
NCT00288886 -
Reinforcement of Abstinence and Continuing Care in Substance Abuse Treatment
|
Phase 2 |